RxDoctor Payments Data

Paul Mahoney, MD

Interventional Cardiology · Greenville, NCNPI 1578539201

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (45.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Medtronic at 40.2% of the total. Reporting peaked in 2023 at $484,655 and has fallen 91.2% since, to $42,508 in 2025. Among interventional cardiology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,692,202in general payments, 2019–2025

Across 2,211 payments — averaging $765.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$680K
  • Edwards Lifesciences$521K
  • Abbott$225K
  • Boston Scientific$191K
  • Abiomed$56K
  • Baylis Medical Company Inc$9K
  • plus $10K from 18 others
$2,276,582in research payments, 2019–2025

Across 487 payments — averaging $4674.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Edwards Lifesciences$1M
  • Abbott$782K
  • Medtronic$250K
  • Boston Scientific$173K
  • Essential Medical, Inc.$21K
  • W. L. Gore & Associates, Inc.$17K

What the payments were for

  • Consulting fees$502,48530%
  • Speaking & faculty fees$770,65646%
  • Grants$6500%
  • Travel & lodging$349,47921%
  • Food & beverage$68,7834%
  • Education$1490%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,692,202 in reported general payments places this provider in the 95th percentile of 180 interventional cardiology providers in North Carolina.

See all interventional cardiology providers in North Carolina

Medicare billing

Part B allowed, 2024
$97,934
Medicare patients
205
Services billed
568

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Greenville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →